Delivery Order SPE2DB20D1100-SPE2DB25FA1Q6
Award Date
1/17/25
Potential Completion Date
1/21/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $76,271.02, is a delivery order for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,530.60, and has an ultimate completion date of September 9, 2024. The contract provides for the supply of the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX 300 MG DOSE-2 SYRINGEML. The contract is a delivery order with a firm fixed price of $5,910.93 and an ultimate completion date of August 2, 2024. This award is not associated with a set-aside program. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,369.10, is for the delivery of the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The award has an ultimate completion date of December 27, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, SPE2DB20D2104|SPE2DB25FMGBW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a ceiling value of $1,920.36 and a completion date of January 15, 2025. The contract was awarded on January 14,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $44,176.45 firm-fixed-price delivery order is for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The contract has an ultimate completion date of March 27, 2024.
Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 firm fixed-price contract is a delivery order with an ultimate completion date of January 6, 2025. It provides for the procurement of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $12,280.53, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and expiring in December 2025. This IDC enables the DLA to...
This federal contract award, with the identification number SPE2DB22D1017|SPE2DB25FE9EF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,104.72, is for the delivery of the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2024. This award is not designated as a set-aside...
This federal contract award, with ID SPE2DB22D3011|SPE2DB24FQ3DY, is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4565442069 COSENTYX 300 MG DOSE-2 SYRINGE/ML, a prescription medication. The contract has a ceiling value of $5,821.20 and a completion date of August 14, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office...